SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-087254
Filing Date
2023-08-03
Accepted
2023-08-03 16:06:59
Documents
13
Period of Report
2023-08-01
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322769d1_8k.htm   iXBRL 8-K 58448
  Complete submission text file 0001104659-23-087254.txt   287397

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eqrx-20230801.xsd EX-101.SCH 3833
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eqrx-20230801_def.xml EX-101.DEF 27041
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eqrx-20230801_lab.xml EX-101.LAB 37925
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eqrx-20230801_pre.xml EX-101.PRE 25665
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2322769d1_8k_htm.xml XML 5229
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 (617) 315-2255
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40312 | Film No.: 231139905
SIC: 2834 Pharmaceutical Preparations